A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Debiopharm International SA
Bayer
IDEAYA Biosciences
Calico Life Sciences LLC
SciTech Development, Inc.
Lyell Immunopharma, Inc.
Biogen
Anaveon AG
Molecular Templates, Inc.
National Cancer Institute (NCI)
Shanghai Jiao Tong University School of Medicine
National Cancer Institute (NCI)
Aurigene Discovery Technologies Limited
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Lumos Pharma
Incyte Corporation
Celgene
Halozyme Therapeutics
Guangzhou Institute of Respiratory Disease
Stanford University
University of Kentucky
Cellectar Biosciences, Inc.
Bristol-Myers Squibb
Samsung Medical Center
Pharmacyclics LLC.